Lighthouse Investment Partners’s Cytokinetics CYTK Stock Holding History

Lighthouse Investment Partners’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$635K	–	789
2025 Q4	$635K	Sell	10,000 -37,000	-79%	-$2.3M	0.02%	560
2025 Q3	$2.58M	Buy	47,000 +12,000	+34%	+$494K	0.08%	302
2025 Q2	$1.16M	Buy	+35,000	New	+$1.22M	0.04%	362
2024 Q2	–	Sell	-24,089	Closed	-$1.69M	–	429
2024 Q1	$1.69M	Buy	24,089 +5,159	+27%	+$399K	0.08%	251
2023 Q4	$1.58M	Buy	+18,930	New	+$685K	0.07%	197

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lighthouse Investment Partners's CYTK Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 10,000 shares — an estimated $635K sold.

Lighthouse Investment Partners first reported a position in CYTK in Q4 2023 and held it in 5 quarters. The position peaked at $2.58M in Q3 2025. 440 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

Lighthouse Investment Partners reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 10,000 Cytokinetics shares in Q1 2026, an estimated $635K.
Lighthouse Investment Partners first reported a position in Cytokinetics in Q4 2023 and held it in 5 quarters.
Lighthouse Investment Partners's Cytokinetics position peaked at $2.58M in Q3 2025.
440 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.